Nightingale Health
A blood testing company bringing extensive biological data to routine healthcare.
Launch date
Employees
Market cap
-
Enterprise valuation
€35—53m (Dealroom.co estimates Jan 2021.)
Company register number 1750524-0
Helsinki Uusimaa (HQ)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 2.0m | 2.0m | 2.0m | 2.0m | 2.0m | 2.4m | 3.4m |
% growth | 100 % | - | - | - | - | 21 % | 39 % |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€8.0m | Late VC | ||
N/A | N/A | Series B | |
* | €20.0m | Debt | |
N/A | Late VC | ||
€8.8m | Angel | ||
Total Funding | €25.0m |
Related Content
Recent News about Nightingale Health
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nightingale Health
EditACQUISITION by Nightingale Health Jul 2021
ACQUISITION by Nightingale Health Jan 2022
ACQUISITION by Nightingale Health Mar 2024